Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-guided trigeminal nerve block with ropivacaine for pain after orbital and facial fracture surgery
IRCT20250325065154N1Phase 3Completed
- Sponsor
- Aja University of Medical Sciences
- Start
- Jul 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ropivacaine in Orbital fracture and facial fracture (2 arms), sponsored by Aja University of Medical Sciences. Primary endpoints: Perioperative opioid consumption and Pain after orbital fracture surgery. Started Jul 2026; status: completed.
02
Drugs
ropivacaine
03
Conditions
Orbital fracturefacial fracture
Beyond the preview
Go deeper on IRCT20250325065154N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250325065154N1.